Gael Siwe

Dr. Gael Siwe

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2022 in BioMed Research International
Verified
Journal Article
Open access
OBO. Baponwa
O. Baponwa
AAA. P. Amang
A. P. Amang
CMC. Mezui
C. Mezui
BKB. B. Koubala
B. B. Koubala
GSGael Siwe
Gael Siwe
PTP. V. Tan
P. V. Tan
Paracetamol is a commonly used analgesic/antipyretic whose long‐term intake or overdose is associated with renal and hepatic injuries. The aim of this study was to determine the hepatonephroprotective mechanisms of the aqueous extract of Amblygonocarpus andongensis stem bark (AEAASB) on renal and hepatic failure resulting from paracetamol overdose. Forty‐five rats were divided into nine groups (n = 5); these were treated once daily for 8 days with 5 ml/kg distilled water (normal, negative, and satellite controls); 0.9% normal saline and 140 mg/kg N‐acetyl‐cysteine (positive controls); 125, 250, and 500 mg/kg AEAASB (test groups); and 500 mg/kg AEAASB (satellite test). On day 8 after different treatments, hepatonephrotoxicity was induced in all the groups except the normal group by oral administration of a single dose of paracetamol (1000 mg/kg). Urinary, hematological, serum, and oxidative stress parameters and in vitro antioxidant activity of AEAASB were evaluated. Histological sections of the liver and kidney were performed. AEAASB significantly decreased urea, creatinine, transaminases, alkaline phosphatase, and bilirubin (p < 0.001) at 500 mg/kg compared to the negative control. Significant decreases in hepatic (p < 0.01) and renal (p < 0.001) malondialdehyde levels were associated with increases in superoxide dismutase, catalase, and reduced glutathione levels in 500 mg/kg AEAASB compared with the negative control. Histological analysis showed that AEAASB prevented paracetamol‐induced renal and liver tissue damage. Furthermore, AEAASB revealed a very strong antioxidant activity (inhibitory concentration 50 = 180 μg/ml, antioxidant activity index = 5.55) with an ability to scavenge 63.03% 2,2‐diphenyl‐2‐picrylhy‐drazyl radical and reduced ferric iron by 52.68 mgEqVitC/100 g DM. The hepatonephroprotective effect of AEAASB might result from its ability to improve the antioxidant status through the stimulation of antioxidant factors and the scavenging of free radicals. This property could be ascribed to the presence of some classes of bioactive compounds such as phenolic compounds in great amounts.

9 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HMHauberline Domegne Mikwangock
Hauberline Domegne Mikwangock
Alfred Ngenge TamfuAlfred Ngenge Tamfu
Alfred Ngenge Tamfu
AAAndré Perfusion Amang
André Perfusion Amang
GSGael Siwe
Gael Siwe
CMChristophe Mezui
Christophe Mezui
PTPaul Vernyuy Tan
Paul Vernyuy Tan
Aim. This study is aimed at establishing phenolic compound profile and assessing the possible antiulcer activities of aqueous extracts of some staple plant foods from the West and North‐West regions of Cameroon against chronic gastric ulcer models in rats. Materials and Methods. Phenolic constituents of extracts were evaluated using HPLC‐DAD. Aqueous extracts of Corchorus olitorius, Solanum nigrum, Vigna unguiculata, Triumfetta pentandra, “nkui” spices, and “yellow soup” spices were tested at two doses (200 and 400 mg/kg). After treatments, animals were sacrificed, healing percentage and antioxidant status (catalase, superoxide dismutase, and glutathione peroxidase) were evaluated, and histological examination of gastric mucosa was realized. Results. HPLC‐DAD revealed that p‐hydroxybenzoic and protocatechuic acids were the phenolic compound present in all extracts. Oral administration of extracts (200 and 400 mg/kg) significantly reduced ulcer surface value and significantly increased mucus production compared to the control groups (p < 0.05). Histological study supported the observed healing activity of different extracts characterized by a reduced inflammatory response. Moreover, administration of aqueous extracts increased the activity of antioxidant enzymes. Conclusion. This study revealed that aqueous extracts of Solanum nigrum, Corchorus olitorius, Vigna unguiculata, Triumfetta pentandra, “yellow soup” spices, and “nkui” spices possess healing antiulcer effects against models of gastric ulcers. The antiulcer mechanisms involved may include increase of gastric mucus production and improvement of the antioxidant activity of gastric tissue. These activities may be due to the phenolic compounds identified in the extracts, especially p‐hydroxybenzoic and protocatechuic acids present in all extracts and with known antioxidant, cytoprotective, and healing properties. However, all the diets may promote the healing process of chronic ulcers caused by excessive alcohol consumption/stress.

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GSGael Siwe
Gael Siwe
RMRukesh Maharjan
Rukesh Maharjan
AAAndré Perfusion Amang
André Perfusion Amang
CMChristophe Mezui
Christophe Mezui
NZNkwengoua Ernestine Zondegoumba
Nkwengoua Ernestine Zondegoumba
PTPaul Vernyuy Tan
Paul Vernyuy Tan

31 January 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
VVVandza Luc Vandi
Vandza Luc Vandi
AAAndré Perfusion Amang
André Perfusion Amang
CMChristophe Mezui
Christophe Mezui
GSGael Siwe
Gael Siwe
GNGustave Lebeau Otto Ndji
Gustave Lebeau Otto Ndji
PTPaul Vernyuy Tan
Paul Vernyuy Tan
Objective. The objective of this study was to elucidate the antisecretory mechanism of the root bark aqueous extract of Diospyros mespiliformis (RBAEDM) in Wistar rats. Materials and methods. RBAEDM was tested on three experimental animal models of gastric acid hypersecretion including pyloric ligation (PL), PL with histamine, and carbachol pretreatments. The ulcerated surface, mucus mass, pH, gastric acidity, and pepsin activity were determined. Some bioactive compounds revealed by qualitative phytochemistry were quantified. Some markers of oxidative stress in vivo such as malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), and in vitro antioxidant tests (ABTS: 2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid, DPPH: 2,2-diphenyl-2-picrylhydrazyl, and FRAP: ferric reducing antioxidant power) were determined. Results. In the three models studied, RBAEDM resulted in increases in the percentages of inhibition ranging from 9.50 to 59.52% of gastric ulcer and mucus mass. This increase was accompanied by the reduction in acidity and pepsin activity. The administration of RBAEDM resulted in a significant decrease ( , ) in MDA levels correlated with a significant increase ( , ) in CAT and nitrite levels compared with the negative control. RBAEDM has the ability to scavenge ABTS and DPPH radicals and to reduce FRAP, and the inhibitory concentration of 50% (IC50) of the ABTS radical was 220 μg/mL compared with the butylhydroxytoluene (BHT) control (175 μg/mL). Quantitative phytochemistry revealed abundant polyphenols, flavonoids, tannins, saponins, and anthocyanin. Conclusion. RBAEDM protected gastric mucous membrane for gastric acid by mechanisms that would involve both anticholinergic and antihistaminergic pathways.

9 August 2024
Verified
Journal Article
Open access
PDF file
GSGael Siwe
Gael Siwe
EFEmmanuel Adebowale Fajemisin
Emmanuel Adebowale Fajemisin
MMMasala Mugeri
Masala Mugeri
KNKrupa Naran
Krupa Naran
Stefan Dr. Stefan BarthStefan Dr. Stefan Barth
Stefan Dr. Stefan Barth
Atopic dermatitis (AD) represents the most common inflammatory skin disease with a highly intricated immune fingerprint. Until recently, AD management mostly relied on topical corticosteroids, calcineurin inhibitors, and systemic immunosuppressants, with a range of safety and tolerability concerns including toxicity, drug interactions, and contraindications. With the onset of biologics, safer and more targeted therapeutics have become available, displaying various degrees of success in treating AD, but not yet able to meet all the needs of AD patients. Some of the challenges encountered included variability of responses among patients, long-term safety, and limited access due to prohibitive costs. As the pathophysiology of AD has been increasingly understood within the last years, new approaches are explored, leading to an unprecedented diversification of therapeutic options to address these hurdles. This review highlights current immunotherapeutic strategies developed towards AD, whether already in the clinical pipeline or still in preclinical exploration.

1 January 2020 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Closed access
GSGael Siwe
Gael Siwe
RMRukesh Maharjan
Rukesh Maharjan
AAAndré Perfusion Amang
André Perfusion Amang
CMChristophe Mezui
Christophe Mezui
EZErnestine Nkwengoua Zondegoumba
Ernestine Nkwengoua Zondegoumba
PTPaul Vernyuy Tan
Paul Vernyuy Tan